Skip to Content

Manning & Napier Overseas Series W MNOWX

Medalist Rating as of | See Manning & Napier Advisors Inc. Investment Hub
  • NAV / 1-Day Return 33.14  /  +0.06 %
  • Total Assets 674.9 Mil
  • Adj. Expense Ratio
    0.060%
  • Expense Ratio 0.060%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Foreign Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment
  • Status Open
  • TTM Yield 1.95%
  • Turnover 49%

USD | NAV as of May 18, 2024 | 1-Day Return as of May 18, 2024, 12:16 AM GMT+0

Morningstar’s Analysis MNOWX

Will MNOWX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Manning& Napier Overseas Series W’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MNOWX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 39.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AstraZeneca PLC ADR

5.69 36.4 Mil
Healthcare

Taiwan Semiconductor Manufacturing Co Ltd ADR

5.15 33.0 Mil
Technology

Samsung Electronics Co Ltd

3.94 25.2 Mil
Technology

HDFC Bank Ltd ADR

3.71 23.8 Mil
Financial Services

Canadian National Railway Co

3.59 23.0 Mil
Industrials

Tencent Holdings Ltd

3.50 22.4 Mil
Communication Services

Deutsche Boerse AG

3.44 22.0 Mil
Financial Services

Heineken NV

3.40 21.8 Mil
Consumer Defensive

Techtronic Industries Co Ltd

3.33 21.3 Mil
Industrials

Novartis AG ADR

3.28 21.0 Mil
Healthcare